etc .’ The key here is the power of the data belongs to the data owner . Also , if people give their consent to share their data with chemical researchers , for example , then they get paid for it , which is fairer .”
Not only is this proposed platform built for sharing data , but Schumacher says that other companies could add their services via third party apps and offer to analyse a patient ’ s genes further to get even more insight into their health and wellbeing to report on how they could improve their lifestyle . It ’ s essentially creating an open market .
PAINTING A PICTURE OF SUCCESS According to Schumacher the development and deployment of a unique global genome platform would deliver several advantages for both researchers and , ultimately , the patient . What would the success of a unique global genome ID mean for global healthcare ? “ Firstly , we
can take our data everywhere . To get genomes sequenced is a one in a lifetime investment you can use again and again if you go to the doctor , the hospital or using online services that may help your wellbeing or that of your family . Secondly , it will help researchers make sure they don ’ t analyse the same DNA samples again and again . Dealing with a unique genome platform will save time and money .”
The platform is due to launch around December this year but by that stage only a few services will be available . However , this will change as the community grows . Schumacher is convinced both he and his team are on the verge of something truly groundbreaking and early reviews would indicate he ’ s right . “ We ’ ve had great feedback from all the over the world , including governments and we still have more to announce . We ’ re building something that will truly benefit the whole planet .”
41 www . healthcareglobal . com